Hermona Soreq Selected Research

RNA-Binding Proteins (RNA-Binding Protein)

1/2018	TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis.
2/2012	Nicotinic stimulation induces Tristetraprolin over-production and attenuates inflammation in muscle.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hermona Soreq Research Topics

Disease

31	Inflammation (Inflammations) 04/2022 - 11/2004
25	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 05/2005
17	Parkinson Disease (Parkinson's Disease) 01/2022 - 03/2005
12	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 06/2005
7	Stroke (Strokes) 01/2021 - 07/2010
6	Dementia (Dementias) 04/2022 - 01/2013
6	Neoplasms (Cancer) 01/2020 - 12/2002
5	Neuroinflammatory Diseases 04/2022 - 01/2014
5	Cognitive Dysfunction 04/2022 - 06/2002
5	Pain (Aches) 01/2022 - 10/2013
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 08/2011
5	Myasthenia Gravis 12/2012 - 02/2003
4	Seizures (Absence Seizure) 01/2017 - 10/2010
3	Infections 04/2022 - 11/2007
3	Ischemic Stroke 12/2020 - 07/2010
3	Epilepsy (Aura) 01/2017 - 02/2008
3	Disease Progression 01/2016 - 01/2010
2	Hypersensitivity (Allergy) 04/2022 - 01/2002
2	COVID-19 04/2022 - 01/2020
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018 - 09/2013
2	Status Epilepticus (Complex Partial Status Epilepticus) 01/2018 - 01/2012
2	Poisoning 09/2015 - 10/2010
2	Multiple Sclerosis 09/2013 - 10/2011
2	Wounds and Injuries (Trauma) 02/2012 - 11/2004
2	Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis) 01/2008 - 10/2006
1	Obesity 10/2022
1	Weight Loss (Weight Reduction) 10/2022
1	Encephalitis (Encephalitis, Rasmussen) 04/2022
1	Delirium 04/2022
1	Fibromyalgia (Fibrositis) 01/2022
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Neuromuscular Diseases (Neuromuscular Disease) 01/2021
1	Mental Disorders (Mental Disorder) 11/2020
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2020
1	Human Influenza (Influenza) 01/2020
1	Huntington Disease (Huntington's Disease) 01/2020
1	Schizophrenia (Dementia Praecox) 10/2019
1	Bipolar Disorder (Manic Depressive Psychosis) 10/2019
1	Fatty Liver 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Non-alcoholic Fatty Liver Disease 01/2018
1	Sepsis (Septicemia) 01/2018
1	Body Weight (Weight, Body) 01/2018

Drug/Important Bio-Agent (IBA)

37	Cholinergic Agents (Cholinergics)IBA 04/2022 - 06/2005
24	MicroRNAs (MicroRNA)IBA 04/2022 - 05/2006
21	AcetylcholinesteraseIBA 01/2017 - 06/2002
17	Acetylcholine (Acetylcholine Chloride)FDA Link 04/2022 - 11/2004
14	RNA (Ribonucleic Acid)IBA 04/2022 - 04/2006
11	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2010
11	Messenger RNA (mRNA)IBA 10/2013 - 01/2002
10	Proteins (Proteins, Gene)FDA Link 12/2020 - 03/2002
8	Cholinesterases (Cholinesterase)IBA 09/2016 - 07/2010
8	ButyrylcholinesteraseIBA 07/2014 - 06/2006
7	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2021 - 01/2002
6	Amyloid (Amyloid Fibrils)IBA 01/2020 - 06/2005
5	CytokinesIBA 04/2022 - 12/2009
5	Amyloid beta-PeptidesIBA 01/2019 - 06/2006
5	EnzymesIBA 07/2014 - 11/2007
4	LipidsIBA 10/2022 - 07/2010
4	Pharmaceutical PreparationsIBA 01/2021 - 10/2017
4	Untranslated RNA (Noncoding RNA)IBA 01/2020 - 01/2014
3	Transfer RNA (tRNA)IBA 04/2022 - 12/2020
3	OligonucleotidesIBA 01/2020 - 01/2012
3	Cholinergic ReceptorsIBA 01/2017 - 02/2003
3	EN101IBA 12/2012 - 10/2006
2	LipopolysaccharidesIBA 12/2020 - 01/2016
2	Circular RNAIBA 11/2020 - 01/2020
2	Long Noncoding RNAIBA 01/2020 - 10/2019
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2020 - 01/2020
2	InflammasomesIBA 01/2019 - 01/2017
2	Heterogeneous Nuclear Ribonucleoprotein A1IBA 01/2018 - 09/2013
2	Kainic Acid (Kainate)IBA 01/2018 - 03/2012
2	RNA Precursors (Precursor, mRNA)IBA 01/2018 - 06/2008
2	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 01/2018 - 08/2012
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2018 - 02/2012
2	Adenosine Triphosphate (ATP)IBA 10/2017 - 09/2008
2	Pilocarpine (Ocusert)FDA LinkGeneric 01/2017 - 01/2012
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2017 - 01/2016
2	Toll-Like Receptor 9IBA 11/2016 - 01/2011
2	AntibodiesIBA 01/2016 - 05/2007
2	RNA Splicing FactorsIBA 01/2016 - 09/2013
2	Interleukin-6 (Interleukin 6)IBA 01/2016 - 07/2010
2	Peptides (Polypeptides)IBA 06/2008 - 06/2006
2	InsecticidesIBA 06/2006 - 03/2005
1	Small Untranslated RNAIBA 01/2021
1	Z-Form DNA (Z-DNA)IBA 12/2020
1	Carrier Proteins (Binding Protein)IBA 12/2020
1	NAD (NADH)IBA 01/2020
1	Complement C3 (C3 Complement)IBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	VLDL LipoproteinsIBA 01/2018
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2018
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	Doxycycline (Periostat)FDA LinkGeneric 01/2017

Therapy/Procedure

7	Therapeutics 12/2020 - 05/2007
5	Deep Brain Stimulation 03/2015 - 07/2012
1	Bariatric Surgery 10/2022